HAX1 deletion impairs BCR internalization and leads to delayed BCR-mediated apoptosis

Por Wolkerstorfer, Susanne, Schwaiger, Elisabeth, Rinnerthaler, Mark, Karina Gratz, Iris, Zoegg, Thomas, Brandstetter, Hans, Achatz-Straussberger, Gertrude
Publicado no Cell Mol Immunol (2016)

Minor Antigen Disparities Impede Induction of Long Lasting Chimerism and Tolerance through Bone Marrow Transplantation with Costimulation Blockade

Por Bigenzahn, Sinda, Pree, Ines, Klaus, Christoph, Pilat, Nina, Mahr, Benedikt, Schwaiger, Elisabeth, Nierlich, Patrick, Wrba, Friedrich, Wekerle, Thomas
Publicado no J Immunol Res (2016)

Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning

Por Schwaiger, Elisabeth, Klaus, Christoph, Matheeussen, Veerle, Baranyi, Ulrike, Pilat, Nina, Ramsey, Haley, Korom, Stephan, De Meester, Ingrid, Wekerle, Thomas
Publicado em 2012

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial

Por Eskandary, Farsad, Bond, Gregor, Schwaiger, Elisabeth, Kikic, Zeljko, Winzer, Christine, Wahrmann, Markus, Marinova, Lena, Haslacher, Helmuth, Regele, Heinz, Oberbauer, Rainer, Böhmig, Georg A
Publicado em 2014